For some employers covering GLP-1s, medication goes hand in hand with lifestyle changes
HR Brew
FEBRUARY 27, 2024
Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound are two GLP-1s that have been approved by the Food and Drug Administration (FDA) for weight loss. The class of drugs, called GLP-1, has long been prescribed to treat diabetes but is now available for weight loss as well.
Let's personalize your content